Craneware plc

LSE CRW.L

Craneware plc Price to Sales Ratio (P/S) on January 14, 2025: 4.77

Craneware plc Price to Sales Ratio (P/S) is 4.77 on January 14, 2025, a 3.27% change year over year. Price to sales ratio compares the stock price to the sales per share; higher suggests positive sentiment for future revenue growth.
  • Craneware plc 52-week high Price to Sales Ratio (P/S) is 6.46 on June 03, 2024, which is 35.23% above the current Price to Sales Ratio (P/S).
  • Craneware plc 52-week low Price to Sales Ratio (P/S) is 4.08 on December 20, 2024, which is -14.56% below the current Price to Sales Ratio (P/S).
  • Craneware plc average Price to Sales Ratio (P/S) for the last 52 weeks is 5.48.
Key data
Date Price to Sales Ratio (P/S) Price to Book Ratio (P/B) Dividend Yield Free Cash Flow Yield
Market news
Loading...
LSE: CRW.L

Craneware plc

CEO Mr. Keith Neilson
IPO Date Sept. 13, 2007
Location United Kingdom
Headquarters 1 Tanfield
Employees 747
Sector Technology
Industries
Description

Craneware plc, together with its subsidiaries, develops, licenses, and supports computer software for the healthcare industry in the United States. The company provides solutions, such as Chargemaster Toolkit, an automated software-as-a-service (SaaS) chargemaster management solution for capturing optimal legitimate reimbursement for providers; Trisus Supply, a solution that utilizes data to identify data gaps between the systems; Physician Revenue Toolkit, a SaaS solution for managing physician group KPIs, charges, codes, RVUs, fee schedules, and related information; Reference Plus, a SaaS solution to perform chargemaster analysis; Pharmacy ChargeLink, a solution to enhance charge capture, pricing, and cost management; integration for chargemaster management, a software that automatically uploads chargemaster changes to the patient billing system for accurate billing; Trisus Pricing Analyzer, a SaaS solution that simplifies the price modelling process; and Online Reference Toolkit and supplies assistant solutions. It also offers InSight Medical Necessity, a SaaS solution that provides medical necessity validation for the United States payors and advance beneficiary notice creation; Trisus Claims Informatics, a software that automates claim and coding reviews; and InSight Audit, a web-based audit management application for healthcare organizations to manage government and commercial audits. In addition, the company provides Trisus Healthcare Intelligence, a cost analytics and resource efficiency platform; trisus pricing transparency; InSight Denials to analyze, track, trend, and report on denial data; and appeals services. Further, it offers customer success management and consulting services; professional services; and sales and marketing, and product and software development services. Craneware plc was incorporated in 1999 and is headquartered in Edinburgh, the United Kingdom.

Similar companies

RWS.L

RWS Holdings plc

USD 2.14

0.55%

GBG.L

GB Group plc

USD 3.98

-0.52%

DOTD.L

dotdigital Group Plc

USD 0.97

0.21%

StockViz Staff

January 15, 2025

Any question? Send us an email